Nkarta, Inc. (NKTX) stock
NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.10 (-8.00%)
Close on Nov 18, 2026Market cap $82.37MP/E –Yield 0.00%
Nkarta operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nkarta's operating income for the twelve months ending Jun 30, 2026 was -$132.25M. For fiscal 2025 it was -$122.00M. The highest annual figure on record is -$22.35M in fiscal 2019.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$122.00M | – |
| FY2024 | Dec 31, 2024 | -$128.19M | – |
| FY2023 | Dec 31, 2023 | -$131.65M | – |
| FY2022 | Dec 31, 2022 | -$118.96M | – |
| FY2021 | Dec 31, 2021 | -$86.43M | – |
| FY2020 | Dec 31, 2020 | -$51.51M | – |
| FY2019 | Dec 31, 2019 | -$22.35M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$43.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$30.88M | – |
| Q4 FY2025 | Dec 31, 2025 | -$30.96M | – |
| Q3 FY2025 | Sep 30, 2025 | -$27.29M | – |
| Q2 FY2025 | Jun 30, 2025 | -$27.19M | – |
| Q1 FY2025 | Mar 31, 2025 | -$36.56M | – |
| Q4 FY2024 | Dec 31, 2024 | -$30.92M | – |
| Q3 FY2024 | Sep 30, 2024 | -$33.79M | – |
| Q2 FY2024 | Jun 30, 2024 | -$30.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$32.76M | – |
| Q4 FY2023 | Dec 31, 2023 | -$31.19M | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.29M | – |
| Q2 FY2023 | Jun 30, 2023 | -$36.86M | – |
| Q1 FY2023 | Mar 31, 2023 | -$34.31M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.98M | – |
| Q3 FY2022 | Sep 30, 2022 | -$30.26M | – |
| Q2 FY2022 | Jun 30, 2022 | -$27.61M | – |
| Q1 FY2022 | Mar 31, 2022 | -$26.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.89M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.43M | – |
| Q2 FY2021 | Jun 30, 2021 | -$21.63M | – |
| Q1 FY2021 | Mar 31, 2021 | -$19.48M | – |
| Q4 FY2020 | Dec 31, 2020 | -$18.00M | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.75M | – |
| Q2 FY2020 | Jun 30, 2020 | -$10.36M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.41M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.65M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.91M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.67M | – |
See a number that looks wrong?